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Abstract 
Introduction. This study assessed the Kansas Tracking and Reporting of Controlled Substances 
system (K-TRACS), the online controlled prescription medication monitoring website in Kansas. 
The specific aims were to determine if and when pharmacists and physicians in Kansas were 
using K-TRACS and to identify any perceived benefits or barriers to using K-TRACS.  
Methods. A non-randomized, convenience sample of Kansas pharmacists and family physicians 
were interviewed face to face using a guided semi-structured questionnaire. NVivo 10 (QSR 
International Pty Ltd.) was used to analyze data. 
Results. Ten physicians and sixteen pharmacists were interviewed. All pharmacists and 70% of 
physicians were using K-TRACS. Usage was prompted by encounters with new patients or 
unease with the patient interaction. The perceived benefits included increased communication 
with the patient and all providers, increased provider comfort with treating chronic pain, and 
altered prescriber habits. Barriers to the use of K-TRACS were identified as login, password, and 
operating system problems.  
Conclusions. Among study participants, K-TRACS is used regularly, is perceived to be a benefit 
to providers, patients and communities, and has become a useful new tool in the treatment of 
chronic pain. K-TRACS is perceived to facilitate increased communication between providers 
and with patients.  
KS J Med 2015;8(4):143-150.  
Introduction 
Prescription drug monitoring programs 
(PDMPs) have been identified as an 
important tool for licensed healthcare 
providers, state governments, and licensing 
boards in monitoring controlled prescription 
medication use and misuse.1 PDMPs were 
first utilized in 1939 when California 
launched a program using carbon copies of 
prescriptions and the US postal system to 
relay information about filled prescriptions. 
As of July 2014, forty-nine states and one 
territory have enacted laws to establish 
PDMPs, and forty-eight states have 
operational online systems. PDMPs have 
decreased diversion of controlled 
substances1,2 and doctor shopping for 
controlled prescription medications,3,4,5 to 
alter prescriber habits,4,6 enhanced 
communication between patients and 
physicians,7 and slowed the increase in rates 
of opioid treatment admissions.8 
The Kansas Tracking and Reporting of 
Controlled Substances (K-TRACS) system 
is the PDMP for the state of Kansas. It was 
written into law in 2008 and is an 
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independent (i.e., not integrated into any one 
electronic medical record system) online, 
web-based, proactive data bank under the 
oversight of the Kansas State Board of 
Pharmacy.9 It contains data on all controlled 
prescription medications dispensed in or 
mailed into the state of Kansas from July 
2010 to the present and can be accessed by 
registered licensed healthcare providers. 
Moreover, at the time of our study, data 
from thirteen other states’ PDMPs can be 
accessed through K-TRACS, albeit not from 
states adjoining Kansas.  
Prescription data include the name and 
address of the patient, names of the 
prescriber and dispenser, medication name, 
quantity dispensed, dosage, and date 
dispensed.9 In the state of Kansas, 
individuals or businesses that dispense 
medications are mandated by law to report 
all controlled prescription medications 
dispensed; however, healthcare providers 
who prescribe controlled prescription 
medications are legally not obligated to 
access the system.9 Even though dispensers 
are required to report to KTRACS on a daily 
basis, the system, at the time our data was 
collected, was only updated weekly. Data on 
all scheduled II-IV controlled prescription 
medications, as well as information on three 
additional medications deemed “drugs of 
concern,” are collected.9 These “drugs of 
concern” include promethazine with 
codeine, any compound, mixture or 
preparation that includes prescription 
ephedrine or pseudoephedrine, and 
medications containing the combination of 
butalbital, caffeine, and acetaminophen.9  
Since PDMPs are governed by state law, 
each state’s PDMP is unique and varied in 
its implementation, rules, and participation. 
Evidence-based “best practices” for their 
design, implementation, and use have not 
been determined and are likely to differ by 
location.1,10 Various states have reported the 
impact their unique PDMP has had on their 
health care system,11,12 but the impact of K-
TRACS in the state of Kansas since its 
implementation in July 2010 has not been 
studied. The goal of this project was to 
perform a qualitative assessment of the 
impact of K-TRACS by interviewing 
practicing pharmacists and physicians and 
identify any perceived benefits of the system 
in the areas of patient and community safety, 
practice impact, and chronic pain 
management, as well as any barriers to use 
or operating system problems. 
 
Methods  
Pharmacists and family physicians 
practicing in various communities across 
Kansas including rural and metropolitan 
areas were identified for participation in the 
study. Inclusion criteria for recruitment 
were: (1) being licensed and actively 
practicing in Kansas and (2) consenting to 
participate in a face to face recorded 
interview in their community setting. 
Pharmacists and family physicians from the 
same community or geographic area were 
selected to be interviewed. Practice settings 
included independent and chain retail 
pharmacies as well as solo, group, and 
residency family medicine practices. Study 
participants were interviewed face to face 
using a guided semi-structured 
questionnaire. Implied consent was obtained 
through the interviewee’s verbal responses 
to the questionnaire. Interviews were 
performed from December 2012 through 
March 2013 and conducted primarily by the 
primary investigator and two family 
medicine resident physicians. Each 
interview was conducted in the participant’s 
practice community and averaged 45 
minutes in length. All interviews were 
audiotaped, transcribed, and analyzed.  
Three reviewers independently analyzed 
the transcripts for thematic codes related to 
the benefits and barriers of K-TRACS 
according to qualitative research analysis 
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standards.13 Discrepancies in codes were 
discussed among the group to reach 
consensus. Inter-rater reliability surpassed 
90%. General demographic data in addition 
to the frequency and type of technology 
(laptop/computer, mobile device or email) 
used to access health information were 
collected for all participants. Questions 
regarding K-TRACS’ utilization and the 
benefits of and barriers to using K-TRACS 
were asked of all participants. Multiple 
thematic codes were identified, defined, and 
applied to all transcripts by the three 
reviewers. Study approval was obtained 
through the University’s Institutional 
Review Board.  
 
Results 
Participant characteristics. Ten 
physicians and sixteen pharmacists in 
sixteen different communities were 
interviewed (Figure 1). Sixty percent of the 
physician respondents and 69% of the 
pharmacist respondents were male, 90% of 
the physician respondents and all of the  
 
Figure 1. Location of K-TRACS interviews 
across Kansas.*  
∗ Physicians and phramacists and cities are not 
identified on the map to protect confidentiality 
since several respondents come from rural areas 
where they easily can be identified.  
 
pharmacist respondents were non-Hispanic 
white (Table 1). All of the physician 
respondents were under the age of 61 years 
with the majority (60%) of those 
interviewed between the ages of 31-40 
years. There was greater variation in the 
pharmacist respondents’ age with 31% in the 
51-60 year old age group, and 25% in both 
the 31-40 and 41-50 age groups. When 
asked what technology was used regularly to 
access general healthcare information, all 
responders reported using the internet 
accessed from a laptop or PC. All of the 
physician respondents and 63% of the 
pharmacist respondents used the internet via 
a cell phone. Ninety percent of the physician 
respondents noted accessing information 
from email as well as mobile device 
applications, while only 69% of the 
pharmacist respondents accessed 
information via email and 81% through a 
mobile device application.  
 
Table 1. Participant characteristics (N=26). 
 Physician 
N=10 
N (%) 
Pharmacist 
N=16 
N (%) 
Gender   
Male  6 (60) 11 (69) 
Female 4 (40) 5 (31) 
Age (years)   
21-30 1 (10) 2 (13) 
31-40 6 (60) 4 (25) 
41-50 1 (10) 4 (25) 
51-60 2 (20) 5 (31) 
61-70 0 (0) 1 (6) 
Race/ethnicity   
Non-Hispanic 
White 9 (90) 16 (100) 
Hispanic 1 (10) 0 (0) 
Technology 
used to access 
health 
information 
  
Email 9 (90) 11 (69) 
Internet from 
laptop or PC 10 (100) 16 (100) 
Internet via 
cell phone 10 (100) 10 (63) 
Mobile 
device 
applications 
9 (90) 13 (81) 
Utilization of K-TRACS 
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All of the pharmacist respondents and 
70% of the physician respondents reported 
using K-TRACS for one to three years, 
which demonstrated use from the time K-
TRACS was implemented in 2010. Use 
ranged from occasional to frequent and 
included both personal and staff accession of 
K-TRACS information. Pharmacist 
respondents reported accessing K-TRACS 
more frequently than physician respondents, 
who tended to delegate the task to a 
designated agent. K-TRACS use occurred in 
a variety of settings including pharmacies, 
clinics, emergency departments, hospitals 
and hospices. One physician respondent 
reported that “K-TRACS has been a 
godsend to our program” adding that the 
nurses were “on there [K-TRACS] pulling 
reports up all the time.”  
Several scenarios prompted respondents 
to access a patient’s K-TRACS record 
including a new or unknown patient, a new 
or unknown prescriber or multiple 
prescribers, an unusual quantity or dosage of 
a controlled prescription medication or one 
not usually prescribed in the area, and 
repeated requests for early refills. 
Additionally, pharmacist respondents 
mentioned that patients requesting to pay for 
the medication with cash, particularly one 
that had pharmacy insurance coverage, 
prompted them to check K-TRACS. 
Respondents commented that a patient’s 
behavior, (e.g., “antsy” or “impatient”), or 
their own feelings of discomfort about the 
patient, (e.g., “something just doesn’t feel 
right here”), at the time of the service might 
prompt a K-TRACS inquiry. Respondents 
indicated a report might be requested if the 
provider was perceived to be over-
prescribing, over-dispensing, or practicing 
outside the standards of chronic pain 
management care for the community. 
Benefits 
Study respondents identified many 
perceived benefits of K-TRACS which are 
identified in Table 2. Overall, K-TRACS 
was perceived to have been a benefit to 
community safety by 77% of responders 
with a perceived decrease in the amount of 
doctor and pharmacy shopping by patients. 
One responder noted, “I think that it has 
stopped a lot of this multi-pharmacy, 
multiple doctor, poly-pharmacy, poly-
doctor…it’s very easy to see what they’ve 
been doing. And it does make a difference.”  
Improved patient safety was perceived 
by 81% of responders as a benefit of K-
TRACS. “You know, if we see that 
something’s not adding up then we’ll go to 
K-TRACS or call the physician’s office.” 
Responders reported that K-TRACS helped 
them to set what was perceived to be healthy 
and safer boundaries with patients on 
chronic controlled prescription medications 
and boundaries within the practice setting. 
Respondents reported instances when K-
TRACS facilitated an increase in 
communication between the patient and the 
provider and between the prescriber and the 
pharmacist. As one pharmacist respondent 
said, “We run a K-TRACS and the 
prescriber that prescribed this particular 
prescription didn’t realize that there had 
already been one or two other prescribers. 
So we call them and tell them, they’re like, 
‘thanks for calling’.” This increase in 
communication offered an opportunity to 
improve patient safety and education as well 
as alter some prescriber’s habits. In one 
community, the pharmacist respondent “had 
some concerns because he thought there was 
some over-prescribing. And, he voiced some 
concerns about that. I think the K-TRACS 
allowed him to document that. You know, 
‘this is what you are doing’. And so it was 
very helpful…he [the physician] was 
thanking me for [my partner] doing that to 
help him.” 
Respondents reported that K-TRACS 
provided a surprising increase in their 
comfort level in treating patients needing 
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chronic pain management and an 
improvement in their confidence that they 
were delivering quality care to these 
patients. As one pharmacist respondent said, 
“It helps me feel more confident when I’m 
filling a prescription that I’m taking care of 
the patient the way that they should be…it 
makes me feel a little more confident in my 
practice. That we’re actually doing the right 
thing for people.” 
 
 
Table 2: Benefits and barriers of K-TRACS as identified by physician and pharmacist 
respondents. 
Benefits Barriers 
Supports community safety:  Prevents doctor 
shopping 
Technology: Password, login, and 
system problems 
Increases patient safety: Prevents medication 
abuse and poly-pharmacy 
Time management: Report running is 
time consuming  
Promotes communication among physicians, 
pharmacists, patients and helps to establish 
prescribing boundaries 
Workflow: interrupts clinic/ pharmacy 
workflow to use K-TRACS 
Increases comfort level in chronic pain 
management and confidence in quality of care 
Cost: Revenue loss from using K-
TRACS 
 
Barriers 
Several themes emerged in the barriers 
identified by K-TRACS users. These 
included technological issues, time 
management, workflow disruption, and 
costs, all of which ultimately impact patient 
care. These themes are detailed in Table 2. 
Overall, 96% of responders cited 
technological barriers including forgotten 
passwords, trouble logging on to the system, 
and trouble re-setting passwords. Lack of 
time to run a report was noted by 46% of the 
responders, (e.g., “the truth is we don’t have 
that kind of manpower or time, and 
reimbursements aren’t right to allow that to 
happen”), and an interruption to workflow 
was a problem for 29%. Revenues lost from 
the time spent utilizing K-TRACS was noted 
by 38% of responders.  
Operating system problems were 
described as barriers among those using K-
TRACS. Responders identified several 
problems within the K-TRACS computer 
program. Frequently reported issues  
 
 
 
included an inconsistent reporting of 
compounded controlled prescription 
medications by the system, an inability to 
correct data within K-TRACS after 
submission and lack of real-time data since 
the website is updated only weekly. These 
programming issues have led to inaccurate 
K-TRACS reports and have impacted 
patient care negatively in some situations. 
Additionally, none of the data from states 
that border Kansas can be viewed even 
though data from thirteen other states’ 
PDMPs can be viewed on K-TRACS. This 
was reported as a problem, as was the 
inability to integrate K-TRACS into some 
practice settings’ EMRs. Multiple doctors 
with the same name, lack of a practice 
identifier, and confusing report displays 
(e.g., “when you print it, it prints it in a 
really jumbled way”) were described by 
study participants as program problems.  
 
Discussion 
Among the study respondents, K-
TRACS is used in many clinical situations 
even though it is not required to be used by 
physicians. All of the pharmacist 
respondents and over two-thirds of the 
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physician respondents reported the use of K-
TRACS directly or by staff in their practice. 
Although use does not occur with every 
patient encounter involving controlled 
prescription medications, respondents are 
using it to bring objective data to subjective, 
often emotionally charged patient care 
situations. Additionally, they are using it to 
familiarize themselves with a new patient, 
provider, or prescription. 
K-TRACS is perceived to be performing 
in ways reported of other PDMPs, 
specifically in decreasing the amount of 
doctor shopping3-5 and positively altering 
prescriber habits by promoting the 
appropriate prescribing and dispensing of 
controlled prescription medications.4, 6 
Respondents perceived improvement in 
community safety which might translate into 
a decrease in diversion of controlled 
prescription medications, another reported 
attribute of a PDMP.1,2  
Overall, respondents reported several 
benefits and barriers to the use of K-
TRACS. Among the benefits of using K-
TRACS, respondents pointed to increased 
patient safety and a decrease in pharmacy 
and doctor shopping, which has been shown 
to be a risk factor for drug-related overdose 
death.5,14 Additionally, increased 
communication was a key finding. 
Physicians reported that using K-TRACS 
facilitated communication with their 
patients.15 Moreover, pharmacists reported 
better communication with patients as well 
as with prescribers, which is a novel finding 
for a PDMP. Such communication has been 
shown to improve patient outcomes and 
ensure quality of care for patients with 
chronic disease, which could help 
pharmacists and physicians improve their 
delivery of chronic pain management.15,16 
Among our respondents, the objective data 
of the K-TRACS report seemed to help 
physicians and pharmacists more readily 
discuss any concerns they might have had 
with both the patient as well as with each 
other. These discussions have validated 
prescription decisions, identified the need 
for abuse and addiction treatment, and in 
some instances, decreased prescription 
abuse and overprescribing. These 
discussions additionally could help to 
implement the Institute of Medicine’s report 
on “Preventing Medications Errors” action 
agenda to support the consumer-provider 
partnership, considered a key step in 
improving the safety of the medication-use 
process.17 The report suggests that the “most 
powerful strategy for improving safety may 
be motivating providers and organizations to 
support the full engagement of patients and 
surrogates in improving the safety of 
medication use”. 
Primary care providers often lack 
confidence or feel frustration in treating 
patients with chronic pain.18,19 Our study 
respondents reported that K-TRACS helped 
them feel more confident and comfortable in 
chronic pain treatment. This is a novel 
finding of any PDMP to date. With K-
TRACS, physicians can work in tandem 
with pharmacists to manage complex pain 
patients. Such collaboration can alleviate 
some of the perceived burden of chronic 
pain management. In a state where 
specialists in pain management are, as one 
respondent suggested, “rare as a unicorn,” 
this benefit has the potential to decrease the 
number of family physicians who no longer 
provide chronic pain management and to 
improve access to care for Kansas patients 
who suffer with chronic pain. 
The most frequently cited barrier 
centered on accessing K-TRACS in terms of 
forgotten passwords and frustrations of 
logging into the system. Several important 
problems in the system were identified by 
the interviewees and emerged as significant 
barriers to patient care. Improved reporting 
of compounded controlled prescription 
medications, availability of real-time data, 
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the ability to correct previously reported 
information and greater access to other 
states’ PDMP data, could provide additional 
benefits from the system. 
Limitations. This study provides 
qualitative data from the personal 
experiences of a small number of selected 
pharmacists and family physicians with a 
single state’s PDMP. It may not be reflective 
of the experiences of all pharmacists or 
physicians in Kansas with K-TRACS and 
may not translate to other states’ PDMPs. 
Further studies involving quantitative 
methods across larger study groups are 
needed to determine if these findings are 
representative of the majority of Kansas 
physicians and pharmacists and compare 
that to other states’ PDMPs.  
 
Conclusion 
K-TRACS is being utilized by 
pharmacists and family physicians. K-
TRACS has been a benefit to respondents’ 
practices, patients, and communities, despite 
several operating system barriers. It has 
become an important new tool in their 
treatment of chronic pain and has facilitated 
an increase in communication between the 
physician, pharmacist, and patient. These are 
benefits yet to be reported of a PDMP. 
Efforts to decrease program barriers, 
increase usage, and ensure sustainability and 
funding of the system could extend the 
scope of these identified benefits to more 
providers across the state. 
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